Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway
Hal Barron’s anti-aging biotech has added Vir Biotechnology CSO Herbert “Skip” Virgin to its ranks. At the Rick Klausner-founded Altos Labs, Virgin will lead the Altos Institute of Medicine as medical chief.
The executive will leave Vir at the end of August after nearly five years at the biotech working on treatments for Covid-19, HIV, HBV and flu, the San Francisco company said Thursday morning.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.